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ABSTRACT
Interventional radiologists are physicians who specialize in minimally invasive tar-
geted therapies, offering the most in-depth knowledge of the less invasive therapies 
that are available and diagnostic and clinical experience across all specialties. Inter-
ventional radiologists offer treatments for hepatobiliary diseases without significant 
side effects or damage to the adjacent normal tissue. We briefly introduce some of the 
interventional procedures in gastroenterology.
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1. Introduction
Recently,  medical  science  has  advanced  rapidly, 
and  new  interventional  techniques  for  the  diagnosis 
and  treatment  of  diseases  have  been  introduced. 
Interventional radiology is a safe, less invasive therapy 
with  less  recovery  time  compared  with  open  surgery. 
Gastroenterology  is  a  specialty  that  is  linked  to 
interventional  radiology.  Fortunately,  there  have  been 
significant  advances  in  innovative  radiology  in  the 
diagnosis and treatment of gastroenterology diseases in 
Iran. Patients who have suffered hepatobiliary problems 
benefit  from  interventional  radiology  (IR)  techniques. 
First-line  modern  imaging  modalities,  such  as  duplex 
ultrasonography,  3  and  4  phasic  CT  scan,  and  high-
resolution MRI, have revolutionized the diagnosis and 
management of hepatobiliary diseases. Pioneers in this 
field have performed IR procedures, such as transjugular 
intrahepatic  portosystemic  shunt  (TIPS),  transjugular 
liver  biopsy  (TJLB),  biliary  stent,  and  embolotherapy, 
for  the  hepatobiliary  system.  Recently,  interventional 
radiologists,  in  cooperation  with  gastrohepatologists, 
have played an important role in developing this field of 
medicine. We briefly introduce some of the procedures 
that have been performed in Iran.Hepat Mon. 2011;11(7):507-510
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2. Image-guided liver biopsy 
The safety and efficacy of imaging-guided percutaneous 
biopsies  have  been  well  documented,  and  because 
percutaneous  intervention  is  less  invasive  and  more 
cost-effective than surgery, the number of radiological 
procedures  is  continually  increasing.  CT-guided 
biopsy is the preferred modality for guidance in many 
interventional techniques, due to its ability to provide 
images from different areas. Until recently, liver biopsies 
were  performed  without  guidance,  but  now  these 
procedures  are  being  performed  as  an  image  guided 
technique in Iran.
2. 1. Navigation
In patients who have platelet dysfunction or low platelet 
count  and  in  those  who  have  altered  Protrombine 
Time,  there  is  higher  risk  of  bleeding  after  organ 
biopsy, especially in the liver. We use CT fluoroscopy to 
biopsy  small  lesions.  We  have  published  our  results 
regarding  fluoroscopic  CT  (FCT)  and  have  compared 
it  with  conventional  CT  scan.  The  success  rate  of  FCT 
(92%), however, was significantly (P = 0.019) higher than 
that of CCT (65%) for liver mass biopsies. The mean ± SD 
procedure time for the FCT group was 200 ± 80 sec (20-
400) and 420 ± 260 sec (605-800) for the CCT group (P = 
0.001) (1).
2. 2. Hemorrhage control
We  use  the  coaxial  needle  (TSK  Laboratory/Japan) 
exclusively for liver biopsy, and if we encounter significant 
hemorrhage, we inject 2 cc of gel-foam particles, properly 
mixed with normal saline, via a coaxial needle inside the 
liver biopsy tract, which we have observed is beneficial for 
major hemorrhages. In 55 cases in our center, there were 
no  hemodynamic  changes  that  indicated  hemorrhage 
during recovery.
3.  Transjugular  liver  biopsy  in  patients 
with hemophilia
Most hemophilia patients who were exposed to clotting 
factor concentrates prior to the introduction of effective 
viral inactivation techniques have been exposed to blood-
borne hepatitis viruses. Hepatitis is observed in 40% of 
hemophilic patients and is a major cause of death among 
these  patients.  Liver  biopsy  is  a  necessary  component 
of the evaluation of patients with chronic liver disease, 
particularly in patients who are infected with HCV. A liver 
biopsy is important to help determine the necessity of 
interferon therapy. Transjugular liver biopsy (TJLB) was 
first performed in Iran in 2001 by Ghanaati et al. In our 
opinion, the transjugular route that is associated with 
factor  replacement  is  preferred  in  reducing  the  risks 
of liver biopsy in this population. All transjugular liver 
biopsies were performed by an interventional radiologist. 
Although it was safe and clinically useful, the procedure 
was initially performed by applying suction through the 
biopsy needle, effecting such complications as hematoma 
of the neck at the puncture point, hematoma at the level 
of the brachial plexus, right hypochondriac pain, and 
abdominal  discomfort.  Outpatient  transjugular  liver 
biopsy  is  a  safe  option  in  patients  with  hemophilia, 
avoiding  costly  and  unnecessary  hospital  admissions. 
Patients  with  hemophilia  may  undergo  an  outpatient 
liver biopsy as part of their management of hepatitis C 
infection (2-4). We performed TJLB for the first time in 
Iran in 12 patients with congenital bleeding disorders 
(CBDs)  who  experienced  chronic  HCV  infection  and 
elevated  liver  enzymes  to  determine  its  safety  and 
efficacy. We used the modified Ross needle, with 100% 
transjugular  access  rate  to  the  hepatic  veins  and  92% 
success  rate  in  obtaining  tissue.  The  specimens  that 
were obtained were satisfactory, but only 54.5% could be 
diagnosed histopathologically. Mild hepatitis occurred 
in four patients (36.4%), moderate hepatitis in 5 (45.4%), 
and extended fibrosis or cirrhosis in 2 (18.2%). There were 
2 procedure related complications (16.6%) (5).
4. Transjugular intrahepatic portosystemic 
shunt (TIPS)
The  transjugular  intrahepatic  portosystemic  shunt 
(TIPS)  is  a  percutaneous  intervention  that  creates  a 
portosystemic shunt, which was performed for the first 
time in Iran in 2001 by Ghanaati et al. In this method, the 
shunt is established directly inside the liver by connecting 
one main portal branch with a large hepatic vein. The 
parenchymal  tract  is  kept  open  using  an  expandable 
stent. Based on the diameter of the stent, various amounts 
of portal blood are diverted into systemic circulation, 
resulting in decompression of portal hypertension. TIPS 
is a relatively simple procedure that is usually completed 
in 1 hour. Significant anatomical distortion of the liver or 
abnormalities of the portal vein, including portal vein 
thrombosis,  can  lengthen  the  procedure.  Indications 
include prevention of variceal bleeding, acute bleeding of 
esophageal varices that is refractory to medical therapies, 
esophageal  variceal  rebleeding,  bleeding  from  gastric 
varices, prevention of bleeding from portal hypertensive 
gastropathy and gastric antral vascular ectasia, ascites 
due  to  cirrhosis,  refractory  hepatic  hydrothorax, 
hepatorenal  syndrome,  Budd-Chiari  syndrome,  veno-
occlusive disease, sinusoidal obstruction syndrome, and 
hepatopulmonary syndrome (6, 7).
Absolute contraindications include primary prevention 
of variceal bleeding, congestive heart failure, multiple 
hepatic cysts, uncontrolled systemic infection or sepsis, 
unrelieved  biliary  obstruction,  and  severe  pulmonary 
hypertension.  Relative  contraindications  include 
hepatoma, obstruction of all hepatic veins, portal vein 
thrombosis,  thrombocytopenia  of  less  than  20,000/
cm3,  severe  coagulopathy,  and  moderate  pulmonary 
hypertension.  Common  risks  and  complications 
include  minor  pain,  bruising  and  infection  from  the Hepat Mon. 2011;11(7):507-510
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IV  cannula,  pain  or  discomfort  at  the  puncture  site, 
bleeding  or  bruising,  failure  of  local  anesthetics, 
nerve  damage ( usually  temporary),  pain,  and  mild 
encephalopathy (usually temporary). Less common risks 
and complications consist of infection; damage to the 
surrounding structures, such as blood vessels, organs, 
and  muscles;  excessive  bleeding  from  the  liver;  an 
allergy to the injected drug; and a fast or irregular heart 
beat. Rare risks and complications include rupture of a 
blood vessel, liver failure, severe encephalopathy (brain 
intoxication) and seizures, and cardiac arrest due to local 
anesthetic toxicity.
4.1. Technical success and patient survival
The  success  rate  with  TIPS  for  decompression  of  the 
portal vein has exceeded 90% in most series (6, 7). 
5.  Intravascular  treatment  of  hepatic 
hemangioma
Hepatic  hemangioma  is  a  common  benign  disease. 
Most  such  patients  are  asymptomatic  and  do  require 
intervention,  but  several  are  symptomatic  and  are 
traditionally  treated  by  surgery.  In  the  past  decade, 
interventional  treatment  of  hemangioma,  especially 
large hemangioma, has been effective and is less invasive 
than surgery or radiation therapy. Surgery, which carries 
a  high  risk  of  complications,  requires  more  recovery 
time than transarterial embolization. Radiation therapy 
is effective for hemangiomas with a diameter of less than 
5  cm,  but  for  gigantic  hemangioma,  the  therapeutic 
effect is very limited. In addition, many patients cannot 
tolerate the large radiation dose that is administered. 
Polyvinyl  alcohol ( PVA),  ethanol,  and  lipiodol ( LP) 
emulsions  are  often  used  as  embolizing  agents  for 
transarterial  embolization.  However,  PVA  can  lead  to 
complications, such as pain (8). We embolized 23 patients 
with liver hemangioma. No major complications, such 
as hepatic failure and abscess formation, were observed. 
The majority of our cases (87%) experienced significant 
relief of symptoms.
6. Metallic stenting in the management of 
malignant obstructive jaundice
Malignant obstructive jaundice has a poor prognosis, 
limiting the patient’s lifestyle and survival. Most patients 
will die in the first 6 months after diagnosis. There is 
no  curative  therapy  for  the  disease,  but  stenting  and 
drainage of the biliary system are safe palliative methods 
with few complications. This is now a reliable method 
for  palliation  of  patients  with  obstructive  malignant 
jaundice,  which  is  superior  to  plastic  endoprosthesis, 
considering  patency  rate,  quality  of  life,  complication 
rate,  and  cost.  Percutaneous  biliary  stenting  is  a  safe 
procedure with few technical complications and a high 
success  rate  of  palliation  for  patients  with  malignant 
biliary  jaundice.  Early  complications  are  primarily 
managed  conservatively,  and  most  deaths  are  caused 
by systemic effects of the malignant disease. It is a new 
procedure  in  our  country,  initiated  by  Ghanaati  et  al. 
and results in 50 patients were published in 2010. Such 
academic reports may be used to improve this field (9).
7. Interventional procedures for HCC
Hepatocellular  carcinoma ( HCC)  is  one  of  the  most 
frequent primary malignant tumors in the world, with 
a poor prognosis and a low response rate, and it is the 
fourth leading cause of cancer related death worldwide 
(10). Unfortunately, surgical therapies are suitable for 20% 
of patients; those who are not eligible for surgery should 
receive undergo interventional therapy. The management 
of HCC patients requires cooperation between internists, 
gastroenterologists,  oncologists,  surgeons,  and 
interventional radiologists, and health service providers 
should be asked to participate in this multidisciplinary 
management. In the past decade, various interventional 
procedures have been employed for local control of HCC, 
including  transcatheter  arterial  chemoembolization 
(TACE)  and  many  tumor  ablation  techniques,  such  as 
percutaneous  ethanol  injection ( PEI),  radiofrequency 
ablation ( RFA),  percutaneous  microwave  coagulation 
therapy (PMC), laser-induced interstitial thermotherapy 
(LITT), cryoablation, and acetic acid injection. Based on 
the development of new technologies in imaging and 
drug delivery, it is likely that patients with HCC will be 
treated with combination therapies to improve survival 
(11). At present, these techniques have been introduced to 
academic radiological centers of Iran.
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